MedTrace Logo

Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH)

NCT05423327 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5311

Last updated 2023-03-17

No results posted yet for this study

Summary

Collection of clinical and genetic data to help identify individuals that carry genetic variants of known importance in Non-alcoholic Steatohepatitis (NASH)

Conditions

  • Non-alcoholic Steatohepatitis (NASH)

Interventions

PROCEDURE

No Intervention

Single blood draw

Sponsors & Collaborators

Principal Investigators

  • Clinical Trial Management · Regeneron Pharmaceuticals

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-09
Primary Completion
2022-10-27
Completion
2022-10-27

Countries

  • United States
  • Brazil
  • Mexico
  • Puerto Rico
  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05423327 on ClinicalTrials.gov